FDA Panel Rejects MDMA-Assisted Therapy For PTSD
An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD.
Stay updated with breaking news from Psychedelic Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD.
The panel's recommendation, based on several concerns about two clinical trials, is a serious setback for a promising PTSD treatment.
MDMA is part of a new wave of psychoactive drugs that show great potential for treating conditions such as severe depression and PTSD.
MDMA is part of a new wave of psychoactive drugs that show great potential for treating conditions such as severe depression and PTSD.
Federal health advisers voted Tuesday against a first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD.